| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 |
8-K: Other Events
Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War |
| 03 Nov 2026 | 10-Q 9.30.26 |
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
GAITHERSBURG, Md., November 2, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2026. |
| 16 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
GAITHERSBURG, Md., October 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Richard S. Lindahl, executive vice president, chief financial officer, will retire from the Company effective December 31... |
| 07 Oct 2026 | 144 |
| 07 Oct 2026 |
Form 4: DeGolyer Donald W, Director
Sold 17,800 shares ($126K) |
| 05 Oct 2026 |
Form 4: Williams Paul Anthony, SVP, Products Business
Sold 3,000 shares ($19.6K) |
| 01 Oct 2026 | 144 |
| 14 Sep 2026 |
8-K: Regulation FD Disclosure
1 September 14, 2026 Combating Public Health Threats for Communities Around the World Joe Papa President and Chief Executive Officer H.C. Wainwright 28th Annual Global Investment Conference |
| 01 Sep 2026 |
8-K: Other Events
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) |
| 14 Aug 2026 | SCHEDULE 13G |
| 12 Aug 2026 |
Form 3: Duatschek Stephanie, EVP, CGO
Holds 197,416 shares of Common Stock |
| 06 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +2 more
GAITHERSBURG, Md., August 5, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2026. |
| 31 Jul 2026 | SCHEDULE 13G/A |
| 28 Jul 2026 | SCHEDULE 13G/A |
| 02 Jul 2026 |
Form 4: Williams Paul Anthony, SVP, Products Business
Sold 3,000 shares ($25.2K) |
| 01 Jul 2026 | 144 |
Loading...